[Current possibilities of quality of life improvement in the late stages of Parkinson's disease].  In this review, the authors describe the influence of Parkinson's disease on of the quality of life (QoL) of patients and highlight the importance of this parameter for assessment of treatment efficacy.
Special attention is drawn to improvement of QoL in patients with resistant motor complications using invasive methods based on continuous dopaminergic stimulation.
In the aspect of the influence on QoL, the main results of the studies of levodopa-carbidopa intestinal gel are reviewed.
